comparemela.com

Latest Breaking News On - மலேரியா துணிகர - Page 6 : comparemela.com

World Malaria Day 2021: An interview with Sir Brian Greenwood

World Malaria Day 2021: An interview with Sir Brian Greenwood Thought LeadersSir Brian GreenwoodProfessor of Clinical Tropical MedicineThe London School of Hygiene & Tropical Medicine In observation of World Malaria Day 2021, News-Medical interviews Sir Brian Greenwood about raising awareness for malaria in the times of the COVID-19 pandemic and how we can achieve elimination of the disease. Please can you introduce yourself and tell us about your incredible career in malaria and other tropical diseases in Africa? I am Brian Greenwood and I work at the London School of Hygiene and Tropical Medicine. Before this, I spent 30 years working and living in West Africa. I trained in medicine in the UK and after doing a couple of years of internships, I thought that it would be exciting to go and spend some time in Africa. So I went to Ibadan in Nigeria,  thinking this would be a one or two-year trip as part of my career before coming back to the UK and progressing along the more usual

Researchers investigate leaf extract as an effective anti-malarial medicine

King’s College London Plant-derived agent shows promise in the treatment of malaria. Malaria is caused by the parasite Plasmodium which is transferred to humans by mosquitos feeding on blood. Plasmodium has evolved to evade the human immune system and survive and replicate inside the body. One of these immune evasion mechanisms involves the activation of a particular protein called TGFbeta as soon as the parasite enters the blood. TGFbeta then switches the immune system from killing infected cells to killing bacteria; one way that the parasite can survive within the host environment. Vernonia Amygdalina is a species of plant found predominantly in sub-Saharan Africa, using medicinally by local communities for a variety of diseases, including malaria. Research by Dr Richard Beatson from the School of Cancer & Pharmaceutical Sciences is working to identify the active agent.

GHIT Fund Announces New Investments: A Total of 2 3 Billion Yen in Drugs for Malaria, Tuberculosis, Chagas Disease and Visceral Leishmaniasis, Vaccine for Malaria and Diagnostics for Tuberculosis

GHIT Fund Announces New Investments: A Total of 2 3 Billion Yen in Drugs for Malaria, Tuberculosis, Chagas Disease and Visceral Leishmaniasis, Vaccine for Malaria and Diagnostics for Tuberculosis
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.